Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 750

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

ERK implication in cell cycle regulation

Open access
Chambard, Jean-Claude, Lefloch, Renaud, Pouysségur, Jacques, Lenormand, Philippe·2007·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2006.11.010

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 101

  1. Boulton, 1991, ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF, Cell, 65, 663, 10.1016/0092-8674(91)90098-J · DOI · Paper page
  2. Cooper, 1984, Diverse mitogenic agents induce the phosphorylation of two related 42,000-dalton proteins on tyrosine in quiescent chick cells, Mol. Cell Biol., 4, 30, 10.1128/MCB.4.1.30 · DOI · Paper page
  3. Kohno, 1986, Alpha-thrombin-induced tyrosine phosphorylation of 43,000- and 41,000-Mr proteins is independent of cytoplasmic alkalinization in quiescent fibroblasts, Biochem. J., 238, 451, 10.1042/bj2380451 · DOI
  4. Meloche, 1992, Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity, Mol. Endocrinol., 6, 845
  5. Cook, 1996, Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells, Biochem. J., 320, 237
  6. Kahan, 1992, Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition, J. Biol. Chem., 267, 13369
  7. Tamemoto, 1992, Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells, J. Biol. Chem., 267, 20293
  8. Vouret-Craviari, 1993, Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist, Biochem. J., 289, 209, 10.1042/bj2890209 · DOI · Paper page
  9. Roovers, 2000, Integrating the MAP kinase signal into the G1 phase cell cycle machinery, BioEssays, 22, 818, 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6 · DOI · Paper page
  10. Yamamoto, 2006, Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression, Curr. Biol., 16, 1171, 10.1016/j.cub.2006.04.044 · DOI · Paper page
  11. Jones, 2001, Growth-factor-dependent mitogenesis requires two distinct phases of signalling, Nat. Cell Biol., 3, 165, 10.1038/35055073 · DOI · Paper page
  12. Dikic, 1994, PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation, Curr. Biol., 4, 702, 10.1016/S0960-9822(00)00155-X · DOI · Paper page
  13. Traverse, 1994, EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor, Curr. Biol., 4, 694, 10.1016/S0960-9822(00)00154-8 · DOI · Paper page
  14. Cagnol, 2006, Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death, Apoptosis, 11, 337, 10.1007/s10495-006-4065-y · DOI
  15. Stanciu, 2002, Prolonged nuclear retention of activated extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line, J. Biol. Chem., 277, 4010, 10.1074/jbc.M104479200 · DOI
  16. Xiao, 2002, Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases, Cancer Res., 62, 3615
  17. Tang, 2002, ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53, J. Biol. Chem., 277, 12710, 10.1074/jbc.M111598200 · DOI · Paper page
  18. Hsu, 2005, Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells, J. Pharmacol. Exp. Ther., 313, 333, 10.1124/jpet.104.078808 · DOI · Paper page
  19. Calcabrini, 2006, Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate, Carcinogenesis, 27, 1699, 10.1093/carcin/bgl044 · DOI
  20. Keyse, 1998, Protein phosphatases and the regulation of MAP kinase activity, Semin. Cell Dev. Biol., 9, 143, 10.1006/scdb.1997.0219 · DOI
  21. Pages, 1993, Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation, Proc. Natl. Acad. Sci. U. S. A., 90, 8319, 10.1073/pnas.90.18.8319 · DOI · Paper page
  22. Dudley, 1995, A synthetic inhibitor of the mitogen-activated protein kinase cascade, Proc. Natl. Acad. Sci. U. S. A., 92, 7686, 10.1073/pnas.92.17.7686 · DOI · Paper page
  23. Kamakura, 1999, Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus, J. Biol. Chem., 274, 26563, 10.1074/jbc.274.37.26563 · DOI · Paper page
  24. Mody, 2001, Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway, FEBS Lett., 502, 21, 10.1016/S0014-5793(01)02651-5 · DOI · Paper page
  25. Squires, 2002, Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1, Biochem. J., 366, 673, 10.1042/bj20020372 · DOI
  26. Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
  27. Fischer, 2005, The role of erk1 and erk2 in multiple stages of T cell development, Immunity, 23, 431, 10.1016/j.immuni.2005.08.013 · DOI · Paper page
  28. Brunet, 1999, Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry, EMBO J., 18, 664, 10.1093/emboj/18.3.664 · DOI · Paper page
  29. Formstecher, 2001, PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase, Dev. Cell, 1, 239, 10.1016/S1534-5807(01)00035-1 · DOI · Paper page
  30. Gervais, 2006, Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15, Mol. Biol. Cell, 17, 3940, 10.1091/mbc.E06-06-0501 · DOI
  31. Graves, 2000, Regulation of carbamoyl phosphate synthetase by MAP kinase, Nature, 403, 328, 10.1038/35002111 · DOI · Paper page
  32. Sigoillot, 2005, Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD, J. Biol. Chem., 280, 25611, 10.1074/jbc.M504581200 · DOI
  33. Lenormand, 1998, Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins, J. Cell Biol., 142, 625, 10.1083/jcb.142.3.625 · DOI · Paper page
  34. Soloaga, 2003, MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14, EMBO J., 22, 2788, 10.1093/emboj/cdg273 · DOI · Paper page
  35. Stefanovsky, 2006, Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling, Mol. Cell, 21, 629, 10.1016/j.molcel.2006.01.023 · DOI · Paper page
  36. Stefanovsky, 2006, ERK modulates DNA bending and enhancesome structure by phosphorylating HMG1-boxes 1 and 2 of the RNA polymerase I transcription factor UBF, Biochemistry, 45, 3626, 10.1021/bi051782h · DOI
  37. Waskiewicz, 1999, Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo, Mol. Cell Biol., 19, 1871, 10.1128/MCB.19.3.1871 · DOI · Paper page
  38. Ueda, 2004, Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development, Mol. Cell Biol., 24, 6539, 10.1128/MCB.24.15.6539-6549.2004 · DOI · Paper page
  39. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  40. Inoki, 2005, Signaling by target of rapamycin proteins in cell growth control, Microbiol. Mol. Biol. Rev., 69, 79, 10.1128/MMBR.69.1.79-100.2005 · DOI · Paper page
  41. Roux, 2004, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase, Proc. Natl. Acad. Sci. U. S. A., 101, 13489, 10.1073/pnas.0405659101 · DOI · Paper page
  42. Lavoie, 1996, Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway, J. Biol. Chem., 271, 20608, 10.1074/jbc.271.34.20608 · DOI · Paper page
  43. Weber, 1997, Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase, Biochem. J., 326, 61, 10.1042/bj3260061 · DOI · Paper page
  44. Brown, 1998, Fos family members induce cell cycle entry by activating cyclin D1, Mol. Cell Biol., 18, 5609, 10.1128/MCB.18.9.5609 · DOI · Paper page
  45. Burch, 2004, An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry, Mol. Cell Biol., 24, 4696, 10.1128/MCB.24.11.4696-4709.2004 · DOI
  46. Albanese, 1995, Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions, J. Biol. Chem., 270, 23589, 10.1074/jbc.270.40.23589 · DOI · Paper page
  47. Preston, 2000, Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300, Cell Death Differ., 7, 215, 10.1038/sj.cdd.4400637 · DOI
  48. Baluchamy, 2003, Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity, Proc. Natl. Acad. Sci. U. S. A., 100, 9524, 10.1073/pnas.1633700100 · DOI
  49. Balmanno, 1999, Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells, Oncogene, 18, 3085, 10.1038/sj.onc.1202647 · DOI · Paper page
  50. Gille, 1995, ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation, EMBO J., 14, 951, 10.1002/j.1460-2075.1995.tb07076.x · DOI · Paper page
  51. Murphy, 2004, A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration, Mol. Cell. Biol., 24, 144, 10.1128/MCB.24.1.144-153.2004 · DOI · Paper page
  52. Murphy, 2002, Molecular interpretation of ERK signal duration by immediate early gene products, Nat. Cell Biol., 4, 556, 10.1038/ncb822 · DOI · Paper page
  53. Volmat, 2001, The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases, J. Cell Sci., 114, 3433
  54. Seth, 1991, A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression, J. Biol. Chem., 266, 23521
  55. Daksis, 1994, Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle, Oncogene, 9, 3635
  56. Sherr, 1999, CDK inhibitors: positive and negative regulators of G1-phase progression, Genes Dev., 13, 1501, 10.1101/gad.13.12.1501 · DOI · Paper page
  57. Keenan, 2001, Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase, J. Biol. Chem., 276, 22404, 10.1074/jbc.M100409200 · DOI
  58. Lents, 2002, Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2, J. Biol. Chem., 277, 47469, 10.1074/jbc.M207425200 · DOI
  59. Yoshida, 2003, Mice lacking a transcriptional corepressor Tob are predisposed to cancer, Genes Dev., 17, 1201, 10.1101/gad.1088003 · DOI
  60. Weitzman, 2000, JunD protects cells from p53-dependent senescence and apoptosis, Mol. Cell, 6, 1109, 10.1016/S1097-2765(00)00109-X · DOI · Paper page
  61. Wright, 1999, Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 96, 11335, 10.1073/pnas.96.20.11335 · DOI · Paper page
  62. Roberts, 2002, Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis, Mol. Cell Biol., 22, 7226, 10.1128/MCB.22.20.7226-7241.2002 · DOI
  63. Walsh, 2003, Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx, Mol. Cancer Res., 1, 280
  64. Palmer, 1998, A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1, EMBO J., 17, 5037, 10.1093/emboj/17.17.5037 · DOI · Paper page
  65. Liu, 1999, Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2–cyclin B1 complexes, Mol. Cell. Biol., 19, 5113, 10.1128/MCB.19.7.5113 · DOI
  66. Yan, 2005, BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation, Oncogene, 24, 3285, 10.1038/sj.onc.1208492 · DOI
  67. Rahmouni, 2006, Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence, Nat. Cell Biol., 8, 524, 10.1038/ncb1398 · DOI
  68. Shapiro, 1998, Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen, J. Cell Biol., 142, 1533, 10.1083/jcb.142.6.1533 · DOI · Paper page
  69. Zecevic, 1998, Active MAP kinase in mitosis: localization at kinetochores and association with the motor protein CENP-E, J. Cell Biol., 142, 1547, 10.1083/jcb.142.6.1547 · DOI · Paper page
  70. Cha, 2004, Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies, Biochem. J., 378, 857, 10.1042/bj20031173 · DOI
  71. Hayne, 2004, MEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis, Biochem. Biophys. Res. Commun., 321, 675, 10.1016/j.bbrc.2004.07.024 · DOI
  72. Willard, 2001, MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit, Cell. Signal., 13, 653, 10.1016/S0898-6568(01)00185-1 · DOI
  73. Hirakawa, 1988, Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene, Proc. Natl. Acad. Sci. U. S. A., 85, 1519, 10.1073/pnas.85.5.1519 · DOI
  74. Samuels, 1993, Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase, Mol. Cell. Biol., 13, 6241, 10.1128/MCB.13.10.6241 · DOI · Paper page
  75. Sewing, 1997, High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1, Mol. Cell. Biol., 17, 5588, 10.1128/MCB.17.9.5588 · DOI · Paper page
  76. Woods, 1997, Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1, Mol. Cell. Biol., 17, 5598, 10.1128/MCB.17.9.5598 · DOI · Paper page
  77. Park, 2000, A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes, Mol. Biol. Cell, 11, 2915, 10.1091/mbc.11.9.2915 · DOI
  78. Touitou, 2001, A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome, EMBO J., 20, 2367, 10.1093/emboj/20.10.2367 · DOI · Paper page
  79. Coleman, 2003, Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation, EMBO J., 22, 2036, 10.1093/emboj/cdg189 · DOI
  80. Alt, 2002, p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export, J. Biol. Chem., 277, 8517, 10.1074/jbc.M108867200 · DOI · Paper page
  81. Haluska, 2006, Genetic alterations in signaling pathways in melanoma, Clin. Cancer Res., 12, 2301s, 10.1158/1078-0432.CCR-05-2518 · DOI · Paper page
  82. Mirza, 2004, Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT, Mol. Cell. Biol., 24, 10868, 10.1128/MCB.24.24.10868-10881.2004 · DOI
  83. Yang, 2001, Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc, Oncogene, 20, 1688, 10.1038/sj.onc.1204245 · DOI · Paper page
  84. O'Hagan, 2000, Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression, Genes Dev., 14, 2185, 10.1101/gad.827200 · DOI · Paper page
  85. Medema, 2000, AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1, Nature, 404, 782, 10.1038/35008115 · DOI · Paper page
  86. Stahl, 2002, The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2, J. Immunol., 168, 5024, 10.4049/jimmunol.168.10.5024 · DOI · Paper page
  87. Hoshino, 1999, Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors, Oncogene, 18, 813, 10.1038/sj.onc.1202367 · DOI · Paper page
  88. Sebolt-Leopold, 1999, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo, Nat. Med., 5, 810, 10.1038/10533 · DOI · Paper page
  89. Karasarides, 2004, B-RAF is a therapeutic target in melanoma, Oncogene, 23, 6292, 10.1038/sj.onc.1207785 · DOI · Paper page
  90. Solit, 2006, BRAF mutation predicts sensitivity to MEK inhibition, Nature, 439, 358, 10.1038/nature04304 · DOI · Paper page
  91. Rinehart, 2004, Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer, J. Clin. Oncol., 22, 4456, 10.1200/JCO.2004.01.185 · DOI · Paper page
  92. Kohno, 2006, Targeting the ERK signaling pathway in cancer therapy, Ann. Med., 38, 200, 10.1080/07853890600551037 · DOI · Paper page
  93. Klein, 2006, The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer, Neoplasia, 8, 1, 10.1593/neo.05373 · DOI
  94. Fujioka, 2006, Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes, J. Biol. Chem., 281, 8917, 10.1074/jbc.M509344200 · DOI · Paper page
  95. Lim, 2005, Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance, Cancer Cell, 8, 381, 10.1016/j.ccr.2005.10.014 · DOI · Paper page
  96. Jordan, 2006, Cancer stem cells, N. Engl. J. Med., 355, 1253, 10.1056/NEJMra061808 · DOI · Paper page
  97. Burdon, 1999, Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells, Dev. Biol., 210, 30, 10.1006/dbio.1999.9265 · DOI · Paper page
  98. Burdon, 2002, Signalling, cell cycle and pluripotency in embryonic stem cells, Trends Cell Biol., 12, 432, 10.1016/S0962-8924(02)02352-8 · DOI · Paper page
  99. Hoshino, 2001, Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1), J. Biol. Chem., 276, 2686, 10.1074/jbc.M006132200 · DOI
  100. Gysin, 2005, Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1, Cancer Res., 65, 4870, 10.1158/0008-5472.CAN-04-2848 · DOI
  101. Collisson, 2003, Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade, Cancer Res., 63, 5669

Cited by

See all 750

Metadata

Authors
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2007-08
Volume
1773
Issue
8
Pages
1299-1310
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2122231684
Cited by
750
References
5
FWCI
9.95
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ERK implication in cell cycle regulation. https://app.cochat.ai/papers/10.1016/j.bbamcr.2006.11.010
The paper
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007). ERK implication in cell cycle regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/j.bbamcr.2006.11.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.